ACET
- NASDAQ - CHEMICALS - Specialty Chemicals
Aceto Corp
|
$24.30 |
+0.33
1.38%
|
$24.30
|
$25.00
|
-2.80% |
95,633 83.89%
|
114,000
|
Most Recent Note for ACET - 6/10/2015 12:45:31 PM
This Chemicals - Specialty firm is perched near its 52-week high and within close striking distance of its all-time high. Reported earnings +42% on +17% sales revenues for the Mar '15 quarter, but fundamental concerns remain. Prior quarterly comparisons were not strong and steady above the +25% minimum earnings guideline (C criteria).
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
AZZ
- NYSE - MANUFACTURING - Industrial Equipment & Compone
A Z Z Incorporated
|
$53.80 |
+1.75
3.36%
|
$53.84
|
$52.33
|
2.81% |
103,290 103.29%
|
100,000
|
Most Recent Note for AZZ - 6/10/2015 12:50:14 PM
Hitting new 52-week and all-time highs with above average volume behind today's 4th consecutive gain. Quarterly sales revenues and earnings through Feb '15 as well as its annual earnings history do not match with the fundamental criteria of the fact-based investment system.
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
BRLI
- NASDAQ - HEALTH SERVICES - Medical Laboratories & Researc
Bio Reference Labs Inc
|
$40.33 |
+0.32
0.80%
|
$40.70
|
$46.74
|
-13.71% |
402,051 85.18%
|
472,000
|
Most Recent Note for BRLI - 6/10/2015 12:58:51 PM
Holding its ground near its 52-week high. Gapped up on 6/04/15 after the company agreed to be acquired by Opko Health (OPK) for $1.47 billion. Reported +118% earnings on +15% sales revenues for the Jan '15 quarter, its 2nd consecutive quarterly comparison with earnings well above the +25% minimum guideline (C criteria). Prior results were sub par and fundamental concerns remain.
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
CBPO
- NASDAQ - DRUGS - Biotechnology
China Biologic Products
|
$105.61 |
-0.29 -0.27%
|
$106.50
|
$121.22
|
-12.88% |
825,603 699.66%
|
118,000
|
Most Recent Note for CBPO - 6/10/2015 1:01:17 PM
Pulled back from its 52-week high after proposing a new Public Offering on 6/05/15. It is extended from any sound base. Made steady progress after technically breaking out from a "late-stage" base on 2/17/15. Reported +29% earnings on +25% sales revenues for the Mar '15 quarter and prior earnings increases have been above the +25% minimum (C criteria). Completed an earlier Public Offering on 6/27/14. Following a downturn in FY '10 earnings its annual earnings (A criteria) have been improving.
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
CSFL
- NASDAQ - Banks-Southeast
Centerstate Banks Inc
|
$13.18 |
+0.18
1.38%
|
$13.24
|
$13.12
|
0.46% |
72,641 98.16%
|
74,000
|
Most Recent Note for CSFL - 6/10/2015 1:03:31 PM
Hit another new 52-week high today. Stubbornly held its ground after 3 consecutive volume-driven gains. Found support above its 50 DMA line during its recent advance. Three of the past four quarterly comparisons through Mar '15 showed earnings increases above the +25% minimum guideline (C criteria). Its annual earnings (A criteria) history has not been strong and steady.
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
CUBI
- NASDAQ - Banks-Northeast
Customers Bancorp Inc
|
$27.96 |
+1.27
4.76%
|
$27.97
|
$26.84
|
4.17% |
87,061 81.37%
|
107,000
|
Most Recent Note for CUBI - 6/10/2015 1:08:50 PM
Hitting new all-time with today's 4th consecutive gain, rallying with no resistance remaining due to overhead supply. Showed earnings increases above the +25% minimum guideline (C criteria) in the 3 latest quarters through Mar '15. Prior quarterly and annual earnings history (A criteria) is not a great match with the fact-based investment system's guidelines.
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
CVG
- NYSE - COMPUTER SOFTWARE & SERVICES - Business Software & Services
Convergys Corp
|
$25.64 |
+0.75
3.01%
|
$25.66
|
$25.30
|
1.34% |
470,624 102.31%
|
460,000
|
Most Recent Note for CVG - 6/10/2015 1:10:27 PM
Hitting new 52-week and multi-year highs with today's gain on higher volume, on track for a 6th consecutive weekly gain and getting more extended from any sound base. Quarterly earnings were above the +25% minimum (C criteria) in the 4 latest comparisons through Mar '15. Annual earnings have been improving after a downturn from FY '08 - '11. However, blue triangles beside the annual earnings figures FY '12 to '14 within the graphs used by our experts indicate pre-tax, non-recurring items were included (where possible, such items are normally removed to provide data better suited for comparison).
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
LTXB
- NASDAQ - BANKING - Savings & Loans
LegacyTexas Financial Group Inc
|
$29.07 |
+0.64
2.25%
|
$29.34
|
$28.50
|
2.00% |
171,294 78.94%
|
217,000
|
Most Recent Note for LTXB - 6/10/2015 1:13:13 PM
Hitting a new 52-week high with today's gain challenging its all-time high. Showed better earnings increases in the Dec '14 and Mar '115 quarters, but its prior quarterly and annual earnings (C and A criteria) history is not a match with the fact-based investment system.
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
MATX
- NYSE - Transportation-Ship
Matson Inc
|
$41.68 |
+0.37
0.90%
|
$41.68
|
$43.84
|
-4.93% |
160,494 90.17%
|
178,000
|
Most Recent Note for MATX - 6/10/2015 1:16:16 PM
Consolidating near its 50 DMA line. Prior quarterly earnings increases through Mar '15 have been erratic while sales revenues growth has been sub par, not indicative of a new product or service (N criteria) in great demand. Annual earnings history has been erratic.
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
MSFG
- NASDAQ - BANKING - Regional - Midwest Banks
Mainsource Finl Grp Inc
|
$20.60 |
+0.08
0.39%
|
$20.72
|
$21.08
|
-2.28% |
29,851 80.68%
|
37,000
|
Most Recent Note for MSFG - 6/10/2015 1:19:00 PM
Perched within close striking distance of its 52-week high today following recent gains marked by above average volume. Reported earnings +37% on +11% sales revenues for the Mar '15 quarter, but fundamental concerns remain. Last noted in the 12/19/14 mid-day report with caution - "Quarterly earnings history has not shown strong and steady increases above the +25% minimum guideline (C criteria)."
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
NORD
- NYSE - Consumer Svcs-Education
Nord Anglia Education, Inc
|
$23.79 |
-1.27 -5.05%
|
$25.35
|
$26.87
|
-11.48% |
144,973 154.23%
|
94,000
|
Most Recent Note for NORD - 6/10/2015 1:21:55 PM
Proposed a new Public Offering and gapped down for a damaging loss on the prior session. Slumping further below its 50 DMA line with today's loss. Prior mid-day reports recently cautioned members - "Reported strong earnings increases in the Nov '14 and Feb '15 quarterly comparisons versus the year ago periods. Prior quarterly and annual earnings (C and A criteria) history has not been strong and steady."
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
NVO
- NYSE - DRUGS - Drug Manufacturers - Other
Novo Nordisk A/S Adr
|
$57.90 |
+1.90
3.38%
|
$58.03
|
$57.90
|
-0.01% |
2,174,250 155.53%
|
1,398,000
|
Most Recent Note for NVO - 6/10/2015 1:24:14 PM
This Denmark-based Medical - Ethical Drug firm found support near its 50 DMA line and gapped up today, hitting a new high with its considerable volume-driven gain. Reported earnings +22% on -3% sales revenues for the Mar '15 quarter, and prior quarterly comparisons showed earnings below the +25% guideline (C criteria) with sub par sales revenues growth. A slight downturn in FY '14 hurt its good annual earnings (A criteria) history.
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
OXM
- NYSE - CONSUMER NON-DURABLES - Textile - Apparel Clothing
Oxford Industries Inc
|
$85.61 |
+4.60
5.68%
|
$89.79
|
$82.26
|
4.07% |
509,023 258.39%
|
197,000
|
Most Recent Note for OXM - 6/10/2015 1:26:42 PM
Gapped up hitting new 52-week and multi-year highs with above average volume behind today's 7th consecutive gain. Quarterly comparison through Apr '15 showed sub par sales revenues and earnings increases
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
PGTI
- NASDAQ - Bldg-Constr Prds/Misc
P G T Inc
|
$13.58 |
+0.28
2.11%
|
$13.66
|
$13.63
|
-0.37% |
229,964 84.24%
|
273,000
|
Most Recent Note for PGTI - 6/10/2015 1:29:53 PM
Perched at new 52-week and multi-year highs with today's volume-driven gain. Stubbornly held its ground following a 6/03/15 gap up gain after noted with caution in the mid-day report - "Reported earnings +100% on +52% sales revenues for the Mar '15 quarter, but fundamental concerns remain. Earnings history is not a match with the fact-based investment system's guidelines (C and A criteria). Low-priced stocks are discouraged from consideration unless all key criteria are solidly satisfied."
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
QRVO
- NASDAQ - ELECTRONICS - Semiconductor - Integrated Cir
Qorvo, Inc
|
$81.04 |
+0.99
1.23%
|
$82.03
|
$86.75
|
-6.59% |
2,212,568 121.10%
|
1,827,000
|
Most Recent Note for QRVO - 6/10/2015 1:35:47 PM
Historic studies suggest that as a stock forms a "handle" the volume totals should be lighter, however, QRVO is churning above average volume while consolidating within close striking distance of its 52-week high on the right side of a 12-week cup-with-handle base. Showed encouraging sales revenues acceleration and earnings increases above the +25% minimum guideline (C criteria) in the 4 latest quarterly comparisons through Mar '15. Up and down annual earnings (A criteria) history is a concern.
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
REGN
- NASDAQ - DRUGS - Biotechnology
Regeneron Pharmaceutical
|
$510.06 |
-16.03 -3.05%
|
$510.50
|
$544.00
|
-6.24% |
1,195,043 158.70%
|
753,000
|
Most Recent Note for REGN - 6/10/2015 1:44:18 PM
No overhead supply exists to act as resistance, however, it is extended from any sound base. Gapped down today following a "negative reversal" on the prior session after touching a new 52-week high. Patient investors may watch for a new base or secondary buy point to possibly develop and be noted in the weeks ahead. Three of the past 4 quarterly comparisons through Mar '15 showed earning increases above the +25% minimum guideline (C criteria). Annual earnings (A criteria) history has been strong since FY '12 following years of losses.
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
SFBS
- NASDAQ - BANKING - Regional - Southeast Banks
ServisFirst Bancshares, Inc
|
$36.69 |
+0.58
1.61%
|
$36.80
|
$36.86
|
-0.46% |
46,153 87.08%
|
53,000
|
Most Recent Note for SFBS - 6/10/2015 1:45:16 PM
Rallying near its 52-week high today's gain and no resistance remains due to overhead supply. Stayed above its 50 DMA line while consolidating since noted in the 5/01/15 mid-day report with caution - "Reported earnings +6% on +20% sales revenues for the Mar '15 quarter, a 3rd consecutive quarter below the +25% minimum earnings guideline (C criteria)."
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
VDSI
- NASDAQ - COMPUTER SOFTWARE & SERVICES - Security Software & Services
Vasco Data Security Intl
|
$30.78 |
+0.02
0.05%
|
$31.92
|
$31.84
|
-3.34% |
1,554,409 121.63%
|
1,278,000
|
Most Recent Note for VDSI - 6/10/2015 1:46:35 PM
Touched a new 52-week high today then reversed into the red. Found support at its 200 DMA line during its consolidation since noted in the 2/17/15 mid-day report. Quarterly comparisons through Mar '15 have been strong. Fundamental concerns remain, as prior mid-day reports repeatedly cautioned - "Annual earnings (A criteria) history is not a match with the fact-based investment system's guidelines."
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|